Literature DB >> 3484646

Identification of leukemia cell-derived inhibitory activity (LIA) in conditioned media from human myeloid leukemic cell line ML-2.

V Cukrová, Z Hrkal, H Koprivová, J Neuwirt.   

Abstract

Conditioned media from the human myeloid leukemic cell line ML-2 contain a factor that inhibits the entry of normal CFU-GM into S phase of mitotic cycle as measured by the 3H-TdR suicide technique. This factor was detected in conditioned media prepared by incubating 5 X 10(6) ML-2 cells/ml or 1 X 10(6) ML-2 cells/ml in serum-free RPMI for 5 or 24 hours respectively, and was isolated by ultrafiltration through an XM 300 Diaflo membrane followed by chromatography on Sepharose 6 B. Ferritin, prepared from human placenta, had the same inhibitory effect on CFU-GM. Antibodies against human placental ferritin completely inactivated the inhibitory effect of both human placental ferritin and the factor released from ML-2 cells. The inhibitory activity produced by the cell-line ML-2 was considered as LIA (leukemia cell-derived inhibitory activity) earlier found in HL-60 cell line and AML and CML cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3484646     DOI: 10.1007/BF00320142

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  11 in total

1.  Suppression of normal granulopoiesis in vitro by a leukemia associated inhibitor (LAI) derived from a human promyelocytic cell line [HL-60].

Authors:  T Olofsson; I Olsson
Journal:  Leuk Res       Date:  1980       Impact factor: 3.156

2.  Identification of leukemia-associated inhibitory activity as acidic isoferritins. A regulatory role for acidic isoferritins in the production of granulocytes and macrophages.

Authors:  H E Broxmeyer; J Bognacki; M H Dorner; M de Sousa
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

3.  The prevention of distortion in ultrathin-layer polyacrylamide gel isoelectric focusing.

Authors:  P D Eckersall; J G Conner
Journal:  Anal Biochem       Date:  1984-04       Impact factor: 3.365

4.  Acid isoferritin inhibitory activity.

Authors:  A Jacobs
Journal:  Blood       Date:  1983-09       Impact factor: 22.113

5.  In vitro suppression of normal granulocytic stem cells by inhibitory activity derived from human leukemia cells.

Authors:  H E Broxmeyer; N Jacobsen; J Kurland; N Mendelsohn; A S Moore
Journal:  J Natl Cancer Inst       Date:  1978-03       Impact factor: 13.506

6.  Biochemical characterization of a leukemia-associated inhibitor (LAI) suppressing normal granulopoiesis in vitro.

Authors:  T Olofsson; I Olsson
Journal:  Blood       Date:  1980-06       Impact factor: 22.113

7.  Monocyte-macrophage-derived acidic isoferritins: normal feedback regulators of granulocyte-macrophage progenitor cells in vitro.

Authors:  H E Broxmeyer; J Bognacki; P Ralph; M H Dörner; L Lu; H Castro-Malaspina
Journal:  Blood       Date:  1982-09       Impact factor: 22.113

8.  Isolation and biochemical characterization of leukemia-associated inhibitory activity that suppresses colony and cluster formation of cells.

Authors:  J Bognacki; H E Broxmeyer; J Lobue
Journal:  Biochim Biophys Acta       Date:  1981-01-21

9.  SMALL-SCALE ISOLATION OF FERRITIN FOR THE ASSAY OF THE INCORPORATION OF 14C-LABELLED AMINO ACIDS.

Authors:  J W DRYSDALE; H N MUNRO
Journal:  Biochem J       Date:  1965-06       Impact factor: 3.857

10.  Lactoferrin, transferrin and acidic isoferritins: regulatory molecules with potential therapeutic value in leukemia.

Authors:  H E Broxmeyer; P Gentile; J Bognacki; P Ralph
Journal:  Blood Cells       Date:  1983
View more
  4 in total

1.  Ferritin stimulation of a monokine inhibitor of lipopolysaccharide-augmented myelopoiesis is ferroxidase dependent.

Authors:  R Kreisberg; H E Broxmeyer; R N Moore
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

2.  Neutralization of inhibitory activity derived from cells of MDS patients and ML-2 cell line by monoclonal antibodies against H and L-subunit-rich ferritins.

Authors:  V Cukrová; R Neuwirtová
Journal:  Blut       Date:  1990-11

3.  Leukocyte-derived inhibitory activity in patients with myelodysplastic syndrome.

Authors:  V Cukrová; R Neuwirtová; J Cermák; V Malasková; J Neuwirt
Journal:  Blut       Date:  1987-09

4.  Mutated recombinant human heavy-chain ferritins and myelosuppression in vitro and in vivo: a link between ferritin ferroxidase activity and biological function.

Authors:  H E Broxmeyer; S Cooper; S Levi; P Arosio
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.